We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01571141
Recruitment Status : Completed
First Posted : April 5, 2012
Last Update Posted : April 19, 2012
Information provided by (Responsible Party):
AGUNCO Obstetrics and Gynecology Centre

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given